A detailed history of Acadian Asset Management LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 3,434 shares of APLT stock, worth $31,867. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,434
Holding current value
$31,867
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.35 - $8.5 $14,937 - $29,189
3,434 New
3,434 $29,000
Q4 2023

Feb 13, 2024

BUY
$1.84 - $3.35 $25,187 - $45,858
13,689 New
13,689 $45,000
Q1 2023

May 11, 2023

SELL
$0.75 - $1.21 $29,925 - $48,279
-39,900 Reduced 45.65%
47,495 $38,000
Q3 2022

Nov 14, 2022

BUY
$0.86 - $1.55 $34,884 - $62,872
40,563 Added 86.61%
87,395 $80,000
Q2 2022

Aug 09, 2022

BUY
$0.76 - $2.64 $10,250 - $35,605
13,487 Added 40.45%
46,832 $45,000
Q1 2022

May 12, 2022

BUY
$1.48 - $6.22 $49,350 - $207,405
33,345 New
33,345 $70,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $446M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.